This issue of the Obstetrics and Gynecology Clinics in North America will focus on the
advances in the evaluation and management of Recurrent Pregnancy Loss (RPL) that have …

Antiphospholipid syndrome (APS) is an autoimmune disease manifested by a thrombotic or
obstetrical event in the presence of antiphospholipid antibodies. Obstetrical APS was initially …

Introduction Antiphospholipid syndrome (APS) is an autoimmune disorder manifested by
thromboembolic events, recurrent spontaneous abortions and elevated titers of circulating …

Objective The antiphospholipid syndrome (APS) is a systemic auto-immune disease with an
unclear pathophysiology. The aim of our study was to understand the development of APS …

Antiphospholipid (APL) syndrome is the most common form of acquired thrombophilia. It can
cause significant morbidity and even mortality. The term “APL antibodies” represents a …

There is increasing evidence showing that recurrent thrombosis and intrauterine fetal loss in
antiphospholipid syndrome (APS) are attributable to antiphospholipid (aPL) antibodies. We …

Antiphospholipid syndrome (APS) has been implicated in a range of neuropsychiatric
presentations. However, there is a paucity of systematic studies on APS in psychiatry. This …

El síndrome antifosfolipídico fue definido hace 20 años por Hughes como el estado
trombofílico (arterial y/o venoso) y/o de pérdidas fetales recurrentes en presencia de …

Antiphospholipid syndrome (APS) affects coagulation and the brain by autoimmune
mechanisms. The major antigen in APS is beta-2-glycoprotein I (β2-GPI) is known to …

Currently, Antiphospholipid syndrome is a multidisciplinary problem, as it is one of the
causes of death and disability of patients. Cardiovascular diseases occupy a leading …